Angiotensin II (Ang II) plays a critical role in the diabetic cardiovascular diseases. We have demonstrated that cardiomyocytes with high levels of metallothionein (MT) are significantly resistant to diabetes- and Ang II-induced apoptotic cell death mediated by NOX activation. To investigate the effects of MT on Ang II – induced cardiac injury, we administrated the cardiac MT transgenic (MT-TG) and WT mice with a single injection of Ang II at 1 mg/kg body weight. Ang II caused an increase in apoptosis, examined by TUNEL and Western blot for the caspase-3 activation along with an increased 3-NT formation and an increased expression of NOX isoform p47phox in the membrane proteins 7h after treatment. All these effects of Ang II were significantly prevented in the heart of Ang II-treated MT-TG mice, indicating the protective effect of MT on Ang II-induced apoptosis via suppression of NOX activation. To further evaluate antiapoptotic effect of MT, MT-TG and WT mice were chronically infused with Ang II at 0.5 mg/kg body weight for two weeks and then cardiac tissues were collected at 3 and 6 months. Ang II treatment caused a significant increase in cardiac fibrosis, shown by increased collagen content and up-regulation of connective tissue growth factor in the heart of WT but not in MT-TG mice. These results suggest that Ang II induces cardiac apoptosis through NOX activation and generation of peroxynitrite. MT prevents Ang II-induced cardiac cell death through suppression of NOX activation, peroxynitrite formation and nitrosative damage. The protection of Ang II-induced early cell death by MT leads to a prevention of the late cardiomyopathy.
Read full abstract